Cannabis Rescheduling: Page 13

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next.

US Representative Reintroduces Legislation to Reschedule Cannabis

Rep. Greg Steube has reintroduced the Marijuana 1-to-3 Act, which would reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.

Risky Research

Helpful, or Yet Another Hurdle?

Many industry experts agree President Joe Biden’s three-step cannabis reform plan was historic and removing the plant from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster'—for state-legal markets.

What’s Next for the Cannabis Industry Following the Midterm Elections?

Cannabis-focused attorneys share their predictions for the newly legalized adult-use markets in Maryland and Missouri, as well as how the federal landscape may shift heading into next year.

Texas Congressman Compares ‘In It To Make Money’ Cannabis Industry to Slavery; Alabama Mayor Takes Issue

Rep. Pete Sessions’ comment came during a House subcommittee hearing on federal cannabis reform; Mayor Randall Woodfin called it offensive.

Witnesses Stress Need For Cannabis Descheduling, Uniform Regulation at US House Hearing on Federal Reform

Cannabis advocates say that through federal reform, the U.S. government can work to ensure a thriving industry, social equity and justice in communities of color, treatment for veterans with PTSD and more while reducing the illicit market.

Global Alliance for Cannabis Commerce Discusses Federal and State Cannabis Policy Ahead of Congressional Hearing Testimony

GACC leaders Randal John Meyer and Rezwan Khan broke down some of the industry trade group’s approaches and positions on state and federal reform.

To Reschedule or Deschedule? Plant-Touching Businesses Weigh In

Owners and operators of cannabis companies across the U.S. say they would like to see cannabis completely descheduled as a result of President Joe Biden’s order to review cannabis’s status under the Controlled Substances Act.

Will Cannabis Policy Change?

Past reviews of cannabis’s Schedule I classification in the Controlled Substances Act—the most recent of which took five years and ended in 2016—have never moved the needle with the Drug Enforcement Agency. Many wonder if this time will be different with the directive coming from the president.

Biden's Order to Review Cannabis 'Truly Historic,' But What's at Stake?

Many industry experts agree removing cannabis from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster' for the state-legal industry.

Study Shows Two-Thirds of American Adults Support Biden’s Cannabis Policy Reform Plan

The poll found that nearly three-quarters of respondents support changing how cannabis is classified under federal law and removing it as a Schedule I drug.

Previous Page

Page 13 of 14

Next Page